New analysis shows ideology, not science, drove the global prohibition of psychedelics

A recent study published in Contemporary Drug Problems argues that the strict global prohibition of psychedelic drugs was driven more by political ideology and media panic than by scientific evidence of medical harm. The historical analysis reveals that the 1971 United Nations decision to heavily restrict these substances relied on cultural anxieties rather than genuine public health risks. These findings suggest that current international drug laws may need to be reevaluated to remove unnecessary barriers to modern medical research.

Psychedelics are a diverse class of substances that alter a person’s perception, mood, and cognitive processes. This category includes naturally occurring compounds found in certain plants and mushrooms, like psilocybin and mescaline, as well as synthetic drugs like lysergic acid diethylamide, commonly known as LSD. Medical professionals generally consider these substances to be physiologically safe, and they tend to have a very low risk of causing addiction.

The United Nations is an international organization founded to maintain global peace, security, and cooperation, which includes creating treaties to regulate the global trade of various drugs. In 1971, the United Nations adopted the Convention on Psychotropic Substances. This international treaty classified psychedelics under the strictest possible level of legal control, lumping them together with highly addictive substances.

A psychotropic substance is simply any chemical that alters how the brain functions, causing changes in mood or awareness. In recent years, medical interest in psychedelics has returned. Early research suggests they could help treat severe mental health conditions.

However, the strict international laws established in 1971 continue to make modern medical research very difficult. The scientists conducted this study to understand exactly how international diplomats originally decided to place psychedelics under such extreme restrictions. They wanted to uncover the historical and political forces that shaped these long-standing global drug policies.

“My legal background, an interest in history, and involvement in an organisation that promotes research into the risks and potential benefits of psychedelic compounds coalesced into my wanting to conduct this research,” explained study author Måns Bergkvist of Uppsala University.

To reconstruct the history of UN drug policy, the researchers examined primary historical documents spanning from 1963 to 1971. They gathered archival records from three specific locations: the United Nations Archives, the Swedish National Archives, and the United States National Archives. The scientists analyzed a vast collection of meeting minutes, official negotiation records, internal reports, and diplomatic resolutions.

The researchers specifically focused on documents referencing substances that were not yet under international control. They read through these historical texts using a thematic analysis, which is a method of identifying recurring patterns and ideas within written information. By tracking the positions of different countries, the scientists mapped out how specific legal restrictions were negotiated and finalized during the 1971 convention.

The researchers found that diplomats frequently described psychedelics as a grave public health threat. However, the historical records show that these claims lacked strong scientific backing. Medical studies at the time already indicated a low potential for dependence and a generally favorable safety profile.

Instead of relying on medical data, diplomats appeared to be heavily influenced by sensationalized media reports. During the 1960s, newspapers frequently published exaggerated stories claiming that LSD caused everything from permanent insanity to chromosome damage. French and Soviet diplomats, in particular, used these alarming but unverified news stories to push for immediate global bans.

The scientists also found that psychedelics were framed as a severe social problem linked to youth rebellion. Diplomats connected the drugs to the hippie movement and student protests, viewing the substances as symbols of cultural decay and defiance of authority. Regulating these drugs provided a way for governments to police subcultures that they viewed as politically and socially disruptive.

Discussions about an impending epidemic of drug abuse also dominated the United Nations meetings. Officials frequently argued that psychedelic use would spread rapidly and eliminate a large segment of the population from the workforce. Framing psychedelics as an epidemic allowed diplomats to treat the situation as an ultimate threat to public health and productivity.

Cold War tensions between the United States and the Soviet Union played a major role in the negotiations. Eastern Bloc countries used the issue to criticize capitalist societies, claiming that drug use was a symptom of Western social failure. Western nations responded by emphasizing strict drug control as a commitment to public health and social order, which helped forge a global consensus.

“A particular delegate of the USSR in the United Nations Commission on Narcotic Drugs (CND) offered the most staunch criticism of LSD and urged a global prohibition of clinical research on LSD,” Bergkvist explained. This commission serves as the primary policy-making body for drug-related matters within the United Nations.

This preemptive dismissal of scientific evidence extended to other substances as well. “Two years after the 1971 conference, he stated at a CND session that research (on the subject of cannabis) must be encouraged, but that its findings should not lead the CND to change the current control regimen,” Bergkvist said. “The fact that no delegate at the CND felt it necessary to object to his statement speaks volumes.”

A divide between wealthy industrialized nations and developing agricultural countries also shaped the final treaty. Developing nations pointed out that the treaty placed heavy burdens on their agricultural economies by targeting natural plants. In response, they demanded that wealthy nations take equal responsibility for controlling synthetic laboratory drugs produced within their own borders.

The scientists noted that psychedelics lacked the economic protection enjoyed by other drugs. Sedatives and stimulants were backed by powerful pharmaceutical companies that successfully lobbied to delay regulations on their products. Because psychedelics had no major industry defenders, they became an easy target for strict international prohibition.

“International drug control ultimately is about competing interests, such as culture, geopolitics, and finance,” Bergkvist told PsyPost. “The agreement on the need for the most severe global control measures for psychedelics was so decisive that their actual risks (and even less so their possibly therapeutic potentials) were never considered to a noteworthy extent.”

Many people assume the United States was the primary force pushing for a strict global ban on psychedelics. However, the archival records reveal a very different reality during these negotiations. “I had anticipated the United States’ position would be more pronounced in the deliberations,” Bergkvist said.

“It is commonly perceived, perhaps, that the United States (more or less) forcibly exported the prohibition of psychedelics globally through the Psychotropic Convention,” he explained. “However, the United States remains one of the least visible actors in the development of the prohibition, except in ensuring that clinical research is protected and that the treaty does not affect the use of plants for religious purposes.”

Bergkvist also pointed out that President Richard Nixon personally appointed the members of the delegation representing the United States at the 1971 conference. Ultimately, American diplomats successfully argued that the treaty should not entirely ban the use of naturally occurring psychedelic plants in small religious ceremonies. The delegation also made sure the final treaty included provisions that allowed for limited clinical research to continue.

While this historical analysis provides helpful context, the study does have a few limitations. Archival documents only capture what was formally recorded, meaning that informal conversations or undocumented political pressures might be missing from the historical record. The researchers also focused primarily on the United Nations process, which may not fully represent the domestic political situations within every individual member country.

Future historical research could explore the specific domestic policies of smaller nations that participated in the 1971 convention. Scientists could also investigate how the eventual treaty directly impacted the day-to-day operations of medical laboratories in the years immediately following its passage. A better understanding of this history provides evidence that current global drug classifications are not set in stone and can be adapted as new scientific data emerges.

The study, “Fear and Loathing in the United Nations: The Establishment of International Control of Psychedelics Through the 1971 Convention on Psychotropic Substances,” was authored by Måns Bergkvist, Damon Barrett, Johan Edman, and Björn Johnson.